Guangzhou Mingxing Pharmaceutical

Guangzhou Mingxing Pharmaceutical is a long-standing Chinese pharmaceutical manufacturer and a key subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings. Established in 1900, the company has evolved into a modern enterprise specializing in the production of small molecule chemical drugs and traditional Chinese medicine (TCM) preparations. Its core product line includes treatments for cardiovascular diseases, respiratory ailments, and pediatric conditions, with its Caffeine Citrate Injection being a leading treatment for neonatal apnea in China. The company maintains extensive GMP-certified manufacturing capabilities for various dosage forms, including large and small volume injections, tablets, and capsules. As a "China Time-honored Brand," Mingxing Pharmaceutical plays a vital role in the domestic supply chain for essential medicines and traditional therapies.